International Journal of Geriatric Psychiatry · 2005 · 77 citations · 30 references
MedicineNeurologyNeuroscienceDementiaNeuropsychiatryNeuropsychologyCognitive ImpairmentCognitive NeuropsychologyCognitive SymptomsNeuropsychiatric AssessmentNeuropsychiatric DisordersParkinson DiseaseDementia StagingDisease DurationHallucinations In Parkinson's DiseaseMental State ExaminationNeuropsychological FunctioningNeuropsychological ImpairmentParkinsonian Cognitive ImpairmentVerbal Learning Tests
BACKGROUND: Hallucinations occur in patients with Parkinson's disease (PD) with reported prevalence ranging from 8% to 40%. Hallucinations are significantly associated with dementia in PD, but little is known about possible distinctive cognitive features of non-demented PD patients who develop hallucinations. OBJECTIVE: The aim of the study was to assess selected cognitive abilities in non-demented PD patients with and without hallucinations in order to identify specific neuropsychological correlates of such phenomena. METHODS: Forty-eight consecutive patients with PD and Mini Mental State Examination (MMSE) > or = 23 were examined for the presence of hallucinations and assessed on standardized neuropsychological tasks for semantic and phonological fluency, verbal learning and logical abstract thinking; disease severity was staged according to Hoehn and Yahr scale. RESULTS: Fourteen (29.2%) of 48 patients experienced hallucinations. There was no difference between hallucinators and non-hallucinators on demographic variables, disease severity and dose of any pharmacological treatment. Disease duration was significantly longer in hallucinator vs non-hallucinator patients (p = 0.02). Patients with hallucinations scored significantly lower than patients without hallucinations only on verbal learning-immediate recall task (p = 0.0324), and semantic and phonological fluency tasks (p = 0.0005 and p = 0.0036, respectively). CONCLUSIONS: Our results suggest that PD patients with hallucinations show reduced performance on tasks that explore executive functioning as compared with non-hallucinators. Therefore, executive dysfunction may be considered as a risk factor for the development of hallucinations in non-demented PD patients.
30
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
M. Hamilton · Journal of Neurology Neurosurgery & Psychiatry · 1960 · 32.6K citations · Full text
Margaret M. Hoehn, Melvin D. Yahr · Neurology · 1967 · 12K citations · Full text
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Gilles Fénelon · Brain · 2000 · 1K citations
Medicine, Neurology, Psychiatry +13
FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASE
Ann E. Taylor, Jean A. Saint‐Cyr, Anthony E. Lang · Brain · 1986 · 896 citations